1. Home
  2. CELU vs LOCL Comparison

CELU vs LOCL Comparison

Compare CELU & LOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CELU
  • LOCL
  • Stock Information
  • Founded
  • CELU 2016
  • LOCL 2021
  • Country
  • CELU United States
  • LOCL United States
  • Employees
  • CELU N/A
  • LOCL N/A
  • Industry
  • CELU Biotechnology: Pharmaceutical Preparations
  • LOCL Farming/Seeds/Milling
  • Sector
  • CELU Health Care
  • LOCL Consumer Staples
  • Exchange
  • CELU Nasdaq
  • LOCL Nasdaq
  • Market Cap
  • CELU 56.9M
  • LOCL 54.0M
  • IPO Year
  • CELU N/A
  • LOCL N/A
  • Fundamental
  • Price
  • CELU $1.96
  • LOCL $2.39
  • Analyst Decision
  • CELU Strong Buy
  • LOCL
  • Analyst Count
  • CELU 1
  • LOCL 0
  • Target Price
  • CELU $6.00
  • LOCL N/A
  • AVG Volume (30 Days)
  • CELU 69.1K
  • LOCL 15.5K
  • Earning Date
  • CELU 11-14-2025
  • LOCL 11-12-2025
  • Dividend Yield
  • CELU N/A
  • LOCL N/A
  • EPS Growth
  • CELU N/A
  • LOCL N/A
  • EPS
  • CELU N/A
  • LOCL N/A
  • Revenue
  • CELU $40,578,000.00
  • LOCL $45,978,000.00
  • Revenue This Year
  • CELU N/A
  • LOCL $36.93
  • Revenue Next Year
  • CELU $76.00
  • LOCL $82.62
  • P/E Ratio
  • CELU N/A
  • LOCL N/A
  • Revenue Growth
  • CELU N/A
  • LOCL 31.61
  • 52 Week Low
  • CELU $1.00
  • LOCL $1.18
  • 52 Week High
  • CELU $4.35
  • LOCL $5.75
  • Technical
  • Relative Strength Index (RSI)
  • CELU 57.50
  • LOCL 42.55
  • Support Level
  • CELU $1.62
  • LOCL $2.25
  • Resistance Level
  • CELU $2.29
  • LOCL $2.50
  • Average True Range (ATR)
  • CELU 0.15
  • LOCL 0.23
  • MACD
  • CELU 0.06
  • LOCL 0.00
  • Stochastic Oscillator
  • CELU 63.29
  • LOCL 34.50

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

About LOCL Local Bounti Corporation

Local Bounti Corp is a controlled environment agriculture company. Its business model is based on building local facilities, operated by local teams, to deliver fresh and quality produce to local communities while maintaining a limited carbon footprint. Using proprietary technology to grow leafy greens and herbs in smart greenhouses with a cultivation process that uses less water and land than conventional agriculture, free from herbicides or pesticides, it delivers products that have a longer shelf life, and are good in taste.

Share on Social Networks: